Abstract

Most anaplastic large cell lymphomas (ALCL) express oncogenic fusion proteins derived from chromosomal translocations or inversions of the anaplastic lymphoma kinase (ALK) gene. Frequently ALCL carry the t(2;5) translocation, which fuses the ALK gene to the nucleophosmin (NPM1) gene. The transforming activity mediated by NPM-ALK fusion induces different pathways that control proliferation and survival of lymphoma cells. Grb2 is an adaptor protein thought to play an important role in ALK-mediated transformation, but its interaction with NPM-ALK, as well as its function in regulating ALCL signaling pathways and cell growth, has never been elucidated. Here we show that active NPM-ALK, but not a kinase-dead mutant, bound and induced Grb2 phosphorylation in tyrosine 160. An intact SH3 domain at the C terminus of Grb2 was required for Tyr(160) phosphorylation. Furthermore, Grb2 did not bind to a single region but rather to different regions of NPM-ALK, mainly Tyr(152-156), Tyr(567), and a proline-rich region, Pro(415-417). Finally, shRNA knockdown experiments showed that Grb2 regulates primarily the NPM-ALK-mediated phosphorylation of SHP2 and plays a key role in ALCL cell growth.

Highlights

  • NPM-anaplastic lymphoma kinase (ALK)-induced signaling pathways control cellular proliferation, inhibit apoptosis, and modify cell-cell adhesion and migration [3,4,5,6] and cytoskeleton reorganization and transformation [6, 7]

  • We transfected human HEK-293T with ALKFL, with NPM-ALK (which is both cytoplasmic and nuclear [27]), with its kinase-dead mutant (K210R), with ATIC-ALK, and with a chimeric fusion protein between CD8 and ALK (CD8-ALK) that localizes to the cytoplasmic membrane

  • We have characterized the interaction of the adaptor protein Grb2 with NPM-ALK, the fusion protein involved in the pathogenesis of the anaplastic large cell lymphoma

Read more

Summary

Introduction

NPM-ALK-induced signaling pathways control cellular proliferation, inhibit apoptosis, and modify cell-cell adhesion and migration [3,4,5,6] and cytoskeleton reorganization and transformation [6, 7]. Adaptor proteins Shc (SH2 domain-containing transforming protein), IRS-1 (insulin receptor substrate 1), and Grb bind NPM-ALK directly or in complexes, but their specific role in NPM-ALK-mediated lymphomagenesis is still unclear [2, 8]. The SH2 domain of Grb binds the tyrosine-phosphorylated peptide sequences of receptor tyrosine kinases such as the EGF receptor [14], PDGF receptor [12], and T-cell receptor [15] and of oncogenic fusions such as BCR-ABL [16] and TPR-MET [17]. We found that Tyr160 of Grb is phosphorylated by other oncogenic fusion tyrosine kinases such as TPR-MET, BCR-ABL, and TEL-JAK2, as well as by wild-type receptor tyrosine kinases such as ALK and MET. Grb in NPM-ALK Signaling that Grb is essential for the activation of SHP2 in ALCL and is required for sustained ALCL cell growth

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call